Who owns TRAVERE THERAPEUTICS INC COM?
- Ticker: TVTX
- CUSIP Number: 89422g107
Tip: Access positions for across all investors
Analyze quarterly positions in Travere Therapeutics with up to 7 years of data, all consolidated into one spreadsheet
Download as csvTop investors of Travere Therapeutics stock
Who bought or sold TRAVERE THERAPEUTICS INC COM this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Henderson Group | 11M | $339M | 8% | Mar 2026 |
|
| FMR | 9.6M | $368M | 232% | Dec 2025 |
|
| BlackRock | 7.8M | $232M | -1% | Mar 2026 |
|
| Vanguard Group | 6.3M | $241M | -5% | Dec 2025 |
|
| Armistice Capital | 4.9M | $146M | -27% | Mar 2026 |
|
| State Street Corporation | 4.8M | $182M | 48% | Dec 2025 |
|
| Perceptive Advisors | 4.1M | $123M | -3% | Mar 2026 |
|
| Vanguard Capital Management | 4.0M | $120M | 100% | Mar 2026 |
|
| Nomura Asset Management International | 3.3M | $97M | 100% | Mar 2026 |
|
| Adage Capital Partners GP | 2.9M | $112M | -18% | Dec 2025 |
|
| Kynam Capital Management | 2.4M | $72M | 368% | Mar 2026 |
|
| Geode Capital Management | 2.4M | $70M | 11% | Mar 2026 |
|
| Renaissance Technologies | 2.2M | $86M | 28% | Dec 2025 |
|
| Stephens Investment Management Group | 1.8M | $53M | 4% | Mar 2026 |
|
| Goldman Sachs Group | 1.7M | $51M | -8% | Mar 2026 |
|
| Vanguard Portfolio Management | 1.7M | $51M | 100% | Mar 2026 |
|
| Emerald Advisers | 1.6M | $46M | -2% | Mar 2026 |
|
| Two Sigma Investments | 1.5M | $45M | 30% | Mar 2026 |
|
| Rock Springs Capital Management | 1.5M | $44M | -33% | Mar 2026 |
|
| Bank of America Corporation | 1.3M | $40M | 100% | Mar 2026 |
|
| Eversept Partners | 1.2M | $45M | -17% | Dec 2025 |
|
| MPM Oncology Impact Management | 1.1M | $34M | 100% | Mar 2026 |
|
| Emerald Mutual Fund Advisers, Trust | 945k | $28M | 0% | Mar 2026 |
|
| Nuveen | 939k | $28M | -6% | Mar 2026 |
|
| Deutsche Bank Aktiengesellschaft | 926k | $28M | 5% | Mar 2026 |
|
| Driehaus Capital Management | 901k | $34M | 27% | Dec 2025 |
|
| Fiera Capital Corporation | 901k | $27M | 3% | Mar 2026 |
|
| Susquehanna International | 896k | $34M | 75% | Dec 2025 |
|
| UBS Group | 857k | $26M | 103% | Mar 2026 |
|
| D. E. Shaw & Co | 837k | $25M | -24% | Mar 2026 |
|
| Charles Schwab Investment Management | 808k | $31M | -5% | Dec 2025 |
|
| Wellington Management Company | 799k | $31M | -33% | Dec 2025 |
|
| Northern Trust | 762k | $29M | -8% | Dec 2025 |
|
| RA Capital Management | 747k | $22M | 100% | Mar 2026 |
|
| Ensign Peak Advisors | 716k | $21M | -11% | Mar 2026 |
|
| Caption Management | 691k | $26M | -14% | Dec 2025 |
|
| Vanguard Fiduciary Trust | 613k | $18M | 100% | Mar 2026 |
|
| PanAgora Asset Management | 593k | $18M | 1% | Mar 2026 |
|
| Barclays | 582k | $22M | 67% | Dec 2025 |
|
| Standard Life Aberdeen | 557k | $17M | 7% | Mar 2026 |
|
| Soleus Capital Management | 546k | $16M | 100% | Mar 2026 |
|
| Jane Street | 542k | $16M | -21% | Mar 2026 |
|
| Pictet Asset Management Holding SA | 530k | $15M | -1% | Mar 2026 |
|
| Invesco | 524k | $16M | 10% | Mar 2026 |
|
| Citadel Advisors | 481k | $14M | 59% | Mar 2026 |
|
| Legal & General Group | 451k | $13M | -16% | Mar 2026 |
|
| Qube Research & Technologies | 406k | $16M | -29% | Dec 2025 |
|
| Hsbc Holdings | 397k | $12M | 100% | Mar 2026 |
|
| Candriam Luxembourg S.C.A. | 370k | $11M | -21% | Mar 2026 |
|
| Jacobs Levy Equity Management | 369k | $11M | 37% | Mar 2026 |
|
| AQR Capital Management | 305k | $9.1M | -13% | Mar 2026 |
|
| Woodline Partners | 303k | $9.0M | 84% | Mar 2026 |
|
| Morgan Stanley | 302k | $9.0M | -79% | Mar 2026 |
|
| Affinity Asset Advisors | 300k | $12M | -40% | Dec 2025 |
|
| New York State Common Retirement Fund | 293k | $8.7M | 18% | Mar 2026 |
|
| First Trust Advisors | 269k | $8.0M | -21% | Mar 2026 |
|
| Arrowstreet Capital, Limited Partnership | 268k | $10M | -18% | Dec 2025 |
|
| Palisades Investment Partners | 255k | $7.6M | 85% | Mar 2026 |
|
| Universal- Beteiligungs- und Servicegesellschaft mbH | 247k | $7.3M | 22% | Mar 2026 |
|
| Loomis, Sayles and | 239k | $9.1M | 100% | Dec 2025 |
|
| Russell Investments | 234k | $7.0M | -18% | Mar 2026 |
|
| Palo Alto Investors | 231k | $6.8M | 108% | Mar 2026 |
|
| Impax Asset Management Group | 225k | $6.7M | 0% | Mar 2026 |
|
| Neuberger Berman Group | 218k | $8.3M | 3% | Dec 2025 |
|
| Bank of New York Mellon | 217k | $6.5M | -1% | Mar 2026 |
|
| Marshall Wace | 217k | $8.3M | -63% | Dec 2025 |
|
| Squarepoint Ops | 200k | $5.9M | -37% | Mar 2026 |
|
| Kingdon Capital Management | 200k | $5.9M | 100% | Mar 2026 |
|
| Ing Investment Management | 197k | $5.8M | 26% | Mar 2026 |
|
| Apis Capital Advisors | 186k | $7.1M | 12% | Dec 2025 |
|
| LMR Partners | 184k | $5.5M | 100% | Mar 2026 |
|
| Hillsdale Investment Management | 182k | $5.4M | 3% | Mar 2026 |
|
| Elmind Capital | 178k | $5.3M | 100% | Mar 2026 |
|
| Algert Coldiron Investors | 177k | $5.3M | 18% | Mar 2026 |
|
| Connor, Clark & Lunn Investment Management | 176k | $5.2M | -72% | Mar 2026 |
|
| Hrt Financial | 174k | $5.2M | 100% | Mar 2026 |
|
| Rafferty Asset Management | 169k | $6.5M | 87% | Dec 2025 |
|
| Swiss National Bank | 168k | $5.0M | 1% | Mar 2026 |
|
| Sei Investments | 167k | $4.9M | 25% | Mar 2026 |
|
| F/M Investments | 165k | $4.9M | -2% | Mar 2026 |
|
| Prudential Financial | 162k | $4.8M | -26% | Mar 2026 |
|
| Essex Investment Management | 162k | $4.8M | 2% | Mar 2026 |
|
| CenterBook Partners | 157k | $4.7M | 100% | Mar 2026 |
|
| Alliancebernstein | 144k | $5.5M | 15% | Mar 2026 |
|
| Knott David M Jr | 141k | $4.2M | -24% | Mar 2026 |
|
| Jennifer Ranahan | 141k | $4.2M | -1% | Mar 2026 |
|
| Ubs Global Asset Management Americas | 137k | $4.1M | -37% | Mar 2026 |
|
| Engineers Gate Manager | 137k | $5.2M | 244% | Dec 2025 |
|
| Franklin Resources | 124k | $3.7M | 33% | Mar 2026 |
|
| Y-Intercept | 117k | $3.5M | 197% | Mar 2026 |
|
| Voloridge Investment Management | 114k | $3.4M | -87% | Mar 2026 |
|
| Hennion & Walsh Asset Management | 114k | $3.4M | 14% | Mar 2026 |
|
| Bnp Paribas Arbitrage, Snc | 109k | $3.2M | -84% | Mar 2026 |
|
| California State Teachers Retirement System | 105k | $3.1M | 32% | Mar 2026 |
|
| Rhumbline Advisers | 104k | $3.1M | -6% | Mar 2026 |
|
| Federated Investors | 93k | $2.8M | 36% | Mar 2026 |
|
| Rice Hall James & Associates | 93k | $2.8M | 1% | Mar 2026 |
|
| KVP Capital Advisors | 91k | $2.7M | 0% | Mar 2026 |
|
| Wells Fargo & Company | 89k | $2.7M | -44% | Mar 2026 |
|
| Exome Asset Management | 89k | $3.4M | -43% | Dec 2025 |
|
| Parkman Healthcare Partners | 86k | $3.3M | -75% | Dec 2025 |
|
| Fred Alger Management | 86k | $2.6M | -9% | Mar 2026 |
|
| Capital Fund Management | 86k | $2.6M | 100% | Mar 2026 |
|
| Mackenzie Financial | 76k | $2.2M | 83% | Mar 2026 |
|
| ALPS Advisors | 75k | $2.2M | 3% | Mar 2026 |
|
| Artia Global Partners | 71k | $2.1M | 0% | Mar 2026 |
|
| Quantinno Capital Management | 68k | $2.0M | 354% | Mar 2026 |
|
| ProFund Advisors | 68k | $2.0M | 8% | Mar 2026 |
|
| Oak Ridge Investments | 67k | $2.0M | 1% | Mar 2026 |
|
| Legato Capital Management | 64k | $1.9M | -27% | Mar 2026 |
|
| XTX Topco | 61k | $2.3M | 475% | Dec 2025 |
|
| PDT Partners | 59k | $1.8M | -60% | Mar 2026 |
|
| State of Wisconsin Investment Board | 59k | $2.3M | -34% | Dec 2025 |
|
| Verition Fund Management | 56k | $2.1M | 100% | Dec 2025 |
|
| S & Co | 56k | $1.7M | 0% | Mar 2026 |
|
| Leucadia National Corporation | 55k | $1.6M | 149% | Mar 2026 |
|
| SG Americas Securities | 55k | $1.6M | 60% | Mar 2026 |
|
| Vanguard Asset Management | 55k | $1.6M | 100% | Mar 2026 |
|
| Calamos Advisors | 54k | $1.6M | -25% | Mar 2026 |
|
| Twinbeech Capital | 51k | $1.5M | 100% | Mar 2026 |
|
| Hudson Bay Capital Management | 51k | $1.5M | -94% | Mar 2026 |
|
| Diadema Partners | 50k | $1.9M | 16667% | Dec 2025 |
|
| Mirae Asset Global Etfs Holdings | 49k | $1.5M | 3% | Mar 2026 |
|
| Envestnet Asset Management | 49k | $1.4M | -3% | Mar 2026 |
|
| AH Lisanti Capital Growth | 48k | $1.4M | -65% | Mar 2026 |
|
| CI Private Wealth | 48k | $1.4M | 100% | Mar 2026 |
|
| Jump Financial | 47k | $1.8M | -85% | Dec 2025 |
|
| Guggenheim Capital, LLC Managers | 46k | $1.4M | 24% | Mar 2026 |
|
| MetLife Investment Advisors | 46k | $1.7M | -13% | Dec 2025 |
|
| Voleon Capital Management | 43k | $1.3M | -58% | Mar 2026 |
|
| Creative Planning | 41k | $1.2M | 2% | Mar 2026 |
|
| Victory Capital Management | 40k | $1.5M | -13% | Dec 2025 |
|
| Burney Co/ | 40k | $1.2M | 100% | Mar 2026 |
|
| Manufacturers Life Insurance Company | 40k | $1.2M | 0% | Mar 2026 |
|
| Vanguard Global Advisers | 38k | $1.1M | 100% | Mar 2026 |
|
| Superstring Capital Management | 38k | $1.5M | -29% | Dec 2025 |
|
| Zurcher Kantonalbank | 38k | $1.1M | 22% | Mar 2026 |
|
| Aquatic Capital Management | 35k | $1.1M | -40% | Mar 2026 |
|
| Fisher Investments | 34k | $1.0M | 0% | Mar 2026 |
|
| Tudor Investment Corporation | 33k | $991k | -46% | Mar 2026 |
|
| Royal Bank of Canada | 33k | $855k | 1970% | Mar 2026 |
|
| OpenArc Corporate Advisory | 31k | $921k | 100% | Mar 2026 |
|
| DekaBank Deutsche Girozentrale | 30k | $887k | 0% | Mar 2026 |
|
| Militia Capital Management | 30k | $882k | 100% | Mar 2026 |
|
| Birchview Capital | 29k | $868k | -32% | Mar 2026 |
|
| State of New Jersey Common Pension Fund D | 29k | $863k | 1% | Mar 2026 |
|
| Cresset Asset Management | 29k | $860k | 0% | Mar 2026 |
|
| Gotham Asset Management | 28k | $843k | -49% | Mar 2026 |
|
| Diversified Trust Company | 28k | $837k | 12% | Mar 2026 |
|
| Citigroup | 27k | $806k | 100% | Mar 2026 |
|
| Segall Bryant & Hamill | 27k | $805k | 0% | Mar 2026 |
|
| J. Goldman & Co | 27k | $1.0M | -50% | Dec 2025 |
|
| Intech Investment Management | 23k | $670k | -44% | Mar 2026 |
|
| Springbok Capital Management | 21k | $787k | -56% | Dec 2025 |
|
| Millennium Management | 20k | $594k | -92% | Mar 2026 |
|
| Virtus Investment Advisers | 20k | $750k | -34% | Dec 2025 |
|
| Nomura Holdings | 17k | $514k | -50% | Mar 2026 |
|
| Cinctive Capital Management | 11k | $415k | -89% | Dec 2025 |
|
| Assenagon Asset Management | 7.9k | $236k | -98% | Mar 2026 |
|
| Acadian Asset Management | 2.6k | $77k | -91% | Mar 2026 |
|
Who sold out of Travere Therapeutics?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Macquarie Group | Sep 2025 | 5.0M | $119M |
| Point72 Asset Management | Dec 2025 | 1.2M | $46M |
| Two Sigma Advisers | Dec 2025 | 726k | $28M |
| Tang Capital Management | Dec 2025 | 700k | $27M |
| Jpmorgan Chase & Co | Sep 2025 | 494k | $12M |
| Jennison Associates | Dec 2025 | 256k | $9.8M |
| Frazier Life Sciences Management | Dec 2025 | 242k | $9.2M |
| Lord, Abbett & Co | Dec 2025 | 136k | $5.2M |
| Eudaimonia Asset Management | Dec 2025 | 109k | $4.2M |
| Penserra Capital Management | Dec 2025 | 80k | $3.0M |
| Schroder Investment Management Group | Sep 2025 | 62k | $1.5M |
| Ameriprise Financial | Dec 2025 | 55k | $2.1M |
| Simplex Trading | Sep 2025 | 51k | $1.2M |
| O'Neil Global Advisors | Dec 2025 | 51k | $2.0M |
| RFG Advisory | Dec 2025 | 43k | $1.6M |
| Ikarian Capital | Dec 2025 | 37k | $1.4M |
| Hussman Econometrics Advisors | Dec 2025 | 32k | $1.2M |
| Brevan Howard Capital Management | Dec 2025 | 29k | $1.1M |